Doctors stunned after promising heart drug fails major study
A pharmaceutical company called Novartis tested a heart drug designed to reduce cardiovascular disease. The drug successfully lowered lipoprotein(a), a genetic risk factor for heart problems. However, the drug failed to reduce the rates of heart attacks, strokes, or cardiovascular deaths in patients. The disappointing results surprised doctors who had expected the drug to prevent these serious cardiac events.
8 across the spectrum. Choose a side on the bar to jump to it.
National story. 10 articles from 8 sources. Updated Sep 9, 2026.
How each side is putting it
Left
3 sourcesRan by 5 outlets across the spectrum· Cleveland Plain Dealer, NJ.com / Star-Ledger
Center
3 sourcesRan by 5 outlets across the spectrum· The Oregonian, MLive
Right
2 sourcesDoctors stunned after promising heart drug fails major study
The story so far
2 developments- Sep 4STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
- Sep 9Doctors stunned after promising heart drug fails major study
Who covered each development
Left
Center
Right
No new developments
Quiet for 45 daysLast development · Sep 9 — Doctors stunned after promising heart drug fails major study